Jump to content

Homeostatic model assessment: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Monkbot (talk | contribs)
m Task 18 (cosmetic): eval 9 templates: del empty params (10×);
Adding local short description: "Method to quantify insulin resistance", overriding Wikidata description "method used to quantify insulin resistance and beta-cell function"
 
(12 intermediate revisions by 8 users not shown)
Line 1: Line 1:
The '''homeostatic model assessment''' ('''HOMA''') is a method used to quantify [[insulin resistance]] and [[beta-cell]] function. It was first described under the name HOMA by Matthews ''et al.'' in 1985.
{{Short description|Method to quantify insulin resistance}}
The '''homeostatic model assessment''' ('''HOMA''') is a method used to quantify [[insulin resistance]] and [[Pancreatic beta cell function|beta-cell function]]. It was first described under the name HOMA by Matthews ''et al.'' in 1985.


==Derivation==
==Derivation==
The HOMA authors used data from physiological studies to develop mathematical equations describing glucose regulation as a feedback loop.
The HOMA authors used data from physiological studies to develop mathematical equations describing glucose regulation as a feedback loop.<ref name="pmid386029">{{cite journal|vauthors=Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J | title=Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. | journal=Metabolism | year= 1979 | volume= 28 | issue= 11 | pages= 1086–96 | doi=10.1016/0026-0495(79)90146-X | pmid=386029 }}</ref>
<ref name="pmid386029">{{cite journal|vauthors=Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J | title=Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. | journal=Metabolism | year= 1979 | volume= 28 | issue= 11 | pages= 1086–96 | doi=10.1016/0026-0495(79)90146-X | pmid=386029 }}</ref>
They published computer software that solves the equations, so that insulin resistance and β-cell function can be estimated from fasting glucose and insulin levels. They also published an equation (see below) that gave approximately the same answers as an early version of the computer software.<ref name="Mathews1985">{{cite journal|vauthors=Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC | title=Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. | journal=Diabetologia | year= 1985 | volume= 28 | issue= 7 | pages= 412–9 | pmid=3899825 | doi=10.1007/BF00280883 | doi-access= free }}</ref>
They published computer software that solves the equations, so that insulin resistance and β-cell function can be estimated from fasting glucose and insulin levels. They also published an equation (see below) that gave approximately the same answers as an early version of the computer software.
<ref name="Mathews1985">{{cite journal|vauthors=Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC | title=Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. | journal=Diabetologia | year= 1985 | volume= 28 | issue= 7 | pages= 412–9 | pmid=3899825 | doi=10.1007/BF00280883 | doi-access= free }}</ref>


The computer model has since been improved to a HOMA2 model<ref name="Rudenski">
The computer model has since been improved to a HOMA2 model<ref name="Rudenski">
Line 18: Line 17:
| pmid = 1895955
| pmid = 1895955
| doi = 10.1016/0026-0495(91)90065-5
| doi = 10.1016/0026-0495(91)90065-5
|author1=A. S. Rudenski |author2=D. R. Matthews |author3=J. C. Levy |author4=R. C. Turner }}</ref> to better reflect human physiology and recalibrated to modern insulin assays. In this updated version it is possible to determine insulin sensitivity and β-cell function from paired fasting plasma glucose and [[radioimmunoassay]] insulin, specific insulin, or C-peptide concentrations. The authors recommend the computer software be used wherever possible.
|author1=A. S. Rudenski |author2=D. R. Matthews |author3=J. C. Levy |author4=R. C. Turner }}</ref> to better reflect human physiology and recalibrated to modern insulin assays. In this updated version it is possible to determine insulin sensitivity and β-cell function from paired fasting plasma glucose and [[radioimmunoassay]] insulin, specific insulin, or C-peptide concentrations. The authors recommend the computer software be used wherever possible.<ref name="Wallace2004">{{cite journal|vauthors=Wallace TM, Levy JC, Matthews DR | title=Use and abuse of HOMA modeling. | journal=Diabetes Care | year= 2004 | volume= 27 | issue= 6 | pages= 1487–95 | doi=10.2337/diacare.27.6.1487 | pmid=15161807 | doi-access=free }}</ref><ref name="pmid9839117">{{cite journal|vauthors=Levy JC, Matthews DR, Hermans MP | title=Correct homeostasis model assessment (HOMA) evaluation uses the computer program. | journal=Diabetes Care | year= 1998 | volume= 21 | issue= 12 | pages= 2191–2 | pmid=9839117 | doi= 10.2337/diacare.21.12.2191| s2cid=38671677 }}</ref>
<ref name="Wallace2004">{{cite journal|vauthors=Wallace TM, Levy JC, Matthews DR | title=Use and abuse of HOMA modeling. | journal=Diabetes Care | year= 2004 | volume= 27 | issue= 6 | pages= 1487–95 | doi=10.2337/diacare.27.6.1487 | pmid=15161807 | doi-access=free }}</ref>
<ref name="pmid9839117">{{cite journal|vauthors=Levy JC, Matthews DR, Hermans MP | title=Correct homeostasis model assessment (HOMA) evaluation uses the computer program. | journal=Diabetes Care | year= 1998 | volume= 21 | issue= 12 | pages= 2191–2 | pmid=9839117 | doi= 10.2337/diacare.21.12.2191}}</ref>


==Notes==
==Notes==
Line 35: Line 32:
|}
|}


'''IR''' is insulin resistance and ''' %β ''' is the β-cell function.
'''IR''' is insulin resistance and ''' %β ''' is the β-cell function (more precisely, an index for glucose tolerance, i.e. a measure for the ability to counteract the glucose load).
Insulin is given in [[Insulin (medication)#Dosage units|μU/mL]].<ref name="pmid21537426">{{cite journal | vauthors = Singh B, Saxena A | title = Surrogate markers of insulin resistance: A review | journal = World J Diabetes | volume = 1 | issue = 2 | pages = 36–47 | date = May 2010 | pmid = 21537426 | pmc = 3083884 | doi = 10.4239/wjd.v1.i2.36 }}</ref> Glucose and insulin are both during fasting.<ref name="Mathews1985"/>
Insulin is given in [[Insulin (medication)#Dosage units|μU/mL]].<ref name="pmid21537426">{{cite journal | vauthors = Singh B, Saxena A | title = Surrogate markers of insulin resistance: A review | journal = World J Diabetes | volume = 1 | issue = 2 | pages = 36–47 | date = May 2010 | pmid = 21537426 | pmc = 3083884 | doi = 10.4239/wjd.v1.i2.36 | doi-access = free }}</ref> Glucose and insulin are both during fasting.<ref name="Mathews1985"/>


This model correlated well with estimates using the [[Insulin resistance#Measuring insulin resistance|euglycemic clamp method]] (r = 0.88).<ref name="Mathews1985"/>
This model correlated well with estimates using the [[Insulin resistance#Measuring insulin resistance|euglycemic clamp method]] (r = 0.88).<ref name="Mathews1985"/>
Line 44: Line 41:
<ref name="pmid10382587">{{cite journal|vauthors=Hermans MP, Levy JC, Morris RJ, Turner RC | title=Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. | journal=Diabetologia | year= 1999 | volume= 42 | issue= 6 | pages= 678–87 | pmid=10382587 | doi=10.1007/s001250051215 | doi-access= free }}</ref>
<ref name="pmid10382587">{{cite journal|vauthors=Hermans MP, Levy JC, Morris RJ, Turner RC | title=Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. | journal=Diabetologia | year= 1999 | volume= 42 | issue= 6 | pages= 678–87 | pmid=10382587 | doi=10.1007/s001250051215 | doi-access= free }}</ref>


The approximation formulae above relate to HOMA and are crude estimates of the model near normal levels of glucose and insulin in man. The actual calculated HOMA2 compartmental model is published
The approximation formulae above relate to HOMA and are crude estimates of the model near normal levels of glucose and insulin in man. The actual calculated HOMA2 compartmental model is published
<ref name="pmid23564921">{{cite journal|vauthors=Hill NR, Levy JC, Matthews DR | title=Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2. | journal=Diabetes Care | year= 2013 | volume= 36 | issue= 8 | pages= 2324–30 | doi=10.2337/dc12-0607 | pmc= 3714535| pmid=23564921 }}</ref> and is available as the [http://www.ihoma.co.uk interactive Homeostatic Model Assessment 2 (iHOMA2)].
<ref name="pmid23564921">{{cite journal|vauthors=Hill NR, Levy JC, Matthews DR | title=Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2. | journal=Diabetes Care | year= 2013 | volume= 36 | issue= 8 | pages= 2324–30 | doi=10.2337/dc12-0607 | pmc= 3714535| pmid=23564921 }}</ref> and is [https://www.dtu.ox.ac.uk/homacalculator/ available online].

== See also ==
* [[Quantitative insulin sensitivity check index|QUICKI]]
* [[SPINA-GBeta]]
* [[SPINA-GR]]


==References==
==References==
Line 51: Line 53:


==External links==
==External links==
*https://web.archive.org/web/20140516232719/http://ihoma.co.uk/
* [https://web.archive.org/web/20140516232719/http://ihoma.co.uk/ iHOMA - Nathan R Hill - University of Oxford]
*https://www.phc.ox.ac.uk/research/technology-outputs/ihoma2
* [https://www.phc.ox.ac.uk/research/technology-outputs/ihoma2 iHOMA2 — Nuffield Department of Primary Care Health Sciences, University of Oxford]


{{DEFAULTSORT:Homeostatic Model Assessment}}
{{DEFAULTSORT:Homeostatic Model Assessment}}

Latest revision as of 11:49, 27 June 2024

The homeostatic model assessment (HOMA) is a method used to quantify insulin resistance and beta-cell function. It was first described under the name HOMA by Matthews et al. in 1985.

Derivation[edit]

The HOMA authors used data from physiological studies to develop mathematical equations describing glucose regulation as a feedback loop.[1] They published computer software that solves the equations, so that insulin resistance and β-cell function can be estimated from fasting glucose and insulin levels. They also published an equation (see below) that gave approximately the same answers as an early version of the computer software.[2]

The computer model has since been improved to a HOMA2 model[3] to better reflect human physiology and recalibrated to modern insulin assays. In this updated version it is possible to determine insulin sensitivity and β-cell function from paired fasting plasma glucose and radioimmunoassay insulin, specific insulin, or C-peptide concentrations. The authors recommend the computer software be used wherever possible.[4][5]

Notes[edit]

The HOMA model was originally designed as a special case of a more general structural (HOMA-CIGMA) model that includes the continuous infusion of glucose with model assessment (CIGMA) approach; both techniques use mathematical equations to describe the functioning of the major effector organs influencing glucose/insulin interactions.[6]

The approximating equation for insulin resistance, in the early model, used a fasting plasma sample, and was derived by use of the insulin-glucose product, divided by a constant: (assuming normal-weight, normal subjects < 35 years, having 100% β-cell function an insulin resistance of 1)

Glucose in Molar Units mmol/L Glucose in mass units mg/dL

IR is insulin resistance and is the β-cell function (more precisely, an index for glucose tolerance, i.e. a measure for the ability to counteract the glucose load). Insulin is given in μU/mL.[7] Glucose and insulin are both during fasting.[2]

This model correlated well with estimates using the euglycemic clamp method (r = 0.88).[2]

The authors have tested HOMA and HOMA2 extensively against other measures of insulin resistance (or its reciprocal, insulin sensitivity) and β-cell function.[4] [8] [9]

The approximation formulae above relate to HOMA and are crude estimates of the model near normal levels of glucose and insulin in man. The actual calculated HOMA2 compartmental model is published [10] and is available online.

See also[edit]

References[edit]

  1. ^ Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J (1979). "Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations". Metabolism. 28 (11): 1086–96. doi:10.1016/0026-0495(79)90146-X. PMID 386029.
  2. ^ a b c Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985). "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man". Diabetologia. 28 (7): 412–9. doi:10.1007/BF00280883. PMID 3899825.
  3. ^ A. S. Rudenski; D. R. Matthews; J. C. Levy; R. C. Turner (September 1991). "Understanding insulin resistance: Both glucose resistance and insulin resistance are required to model human diabetes". Metabolism. 40 (9): 908–917. doi:10.1016/0026-0495(91)90065-5. ISSN 0026-0495. PMID 1895955.
  4. ^ a b Wallace TM, Levy JC, Matthews DR (2004). "Use and abuse of HOMA modeling". Diabetes Care. 27 (6): 1487–95. doi:10.2337/diacare.27.6.1487. PMID 15161807.
  5. ^ Levy JC, Matthews DR, Hermans MP (1998). "Correct homeostasis model assessment (HOMA) evaluation uses the computer program". Diabetes Care. 21 (12): 2191–2. doi:10.2337/diacare.21.12.2191. PMID 9839117. S2CID 38671677.
  6. ^ Turner et al. (1993) Measurement of insulin resistance and β-cell function: the HOMA and CIGMA approach. Current topics in diabetes research (eds) F. Belfiore, R. Bergman and G. Molinatti Front Diabetes. Basel, Karger 12: 66-75
  7. ^ Singh B, Saxena A (May 2010). "Surrogate markers of insulin resistance: A review". World J Diabetes. 1 (2): 36–47. doi:10.4239/wjd.v1.i2.36. PMC 3083884. PMID 21537426.
  8. ^ Hermans MP, Levy JC, Morris RJ, Turner RC (1999). "Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes". Diabetes. 48 (9): 1779–86. doi:10.2337/diabetes.48.9.1779. PMID 10480608.
  9. ^ Hermans MP, Levy JC, Morris RJ, Turner RC (1999). "Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes". Diabetologia. 42 (6): 678–87. doi:10.1007/s001250051215. PMID 10382587.
  10. ^ Hill NR, Levy JC, Matthews DR (2013). "Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2". Diabetes Care. 36 (8): 2324–30. doi:10.2337/dc12-0607. PMC 3714535. PMID 23564921.

External links[edit]